During the past decade, Maternal Infant Studies Center (CEMI) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maternal Infant Studies Center (CEMI)" #1 collaborator was "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Maternal Infant Studies Center (CEMI)" are "HIV Infections" (1 trials), "HIV-1-infection" (1 trials) and "Pre-Exposure Prophylaxis of HIV Infection" (1 trials). Many other conditions were trialed in "Maternal Infant Studies Center (CEMI)" in a lesser frequency.

Most popular intervention types in "Maternal Infant Studies Center (CEMI)" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "B/F/TAF" (1 trials), "F/TAF (for US participants only)" (1 trials), "F/TDF" (1 trials), "IMVAMUNE (MVA-BN)" (1 trials) and "Oral Lenacapavir (LEN)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maternal Infant Studies Center (CEMI)" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maternal Infant Studies Center (CEMI)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Maternal Infant Studies Center (CEMI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maternal Infant Studies Center (CEMI), 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".